Substance

ID:758

Names and Identifiers
Synonyms
Cloresidina [DCIT]Decanoylacetaldehyde Sodium SulfideChlorhexidinum [INN-Latin]Chlorhexidine BaseClorhexidina [INN-Spanish]Chlorhexidine GluconateChlorhexidin [Czech]Chlorhexidine
IUPAC Traditional name
chlorhexidine hydrochloride
Brand Name
NolvasanPeridexSavlon BabycareSuperspraySavloclensSoretolSteri-StatTubulicidBrian CareCida-StatDyna-HexHexadolOro-ClenseHibisolPharmaseal Scrub CarePrevacare RSteridoSterilonExidineFimeilHibidilPeriogardRoterseptSodium HouttuyfonamideHibiscrubHibisprayHibistatHibitaneMicrodermPeriochipBioscrubHibiclens
IUPAC name
N-(4-chlorophenyl)-1-3-(6-{N-[3-(4-chlorophenyl)carbamimidamidomethanimidoyl]amino}hexyl)carbamimidamidomethanimidamide
Registration numbers
CAS Number
Properties
Physical Property
Hydrophobicity(logP)
3
Solubility
0.08%(w/v)
Molecule Details
Drug Groups
approved
Description
A disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque. [PubChem]
Indication
For reduction of pocket depth in patients with adult periodontitis, used as an adjunct to scaling and root planing procedures. Also for prevention of dental caries, oropharyngeal decontamination in critically ill patients, hand hygiene in health-care personnel, general skin cleanser, and catheter site preparation and care.
Pharmacology
Chlorhexidine, a topical antimicrobial agent, is bactericidal. Because of its positive charge, the chlorhexidine molecule reacts with the microbial cell surface to destroy the integrity of the cell membrane. This novel mechanism of action makes it highly unlikely for the development of bacterial resistance.
Toxicity
LD50= 2g/kg (human, oral); LD50= 3 g/kg (rat, oral); LD50= 2.5 g/kg (mice, oral); LD50= 21 mg/kg (male rat, IV); LD50= 23 mg/kg (female rat, IV); LD50= 25 mg/kg (male mice, IV); LD50= 24 mg/kg (female mice, IV); LD50= 1g/kg (rat, subcutaneous); LD50= 637 mg/kg (male mice, subcutaneous); LD50= 632 mg/kg (female mice, subcutaneous)
Affected Organisms
Bacteria
Absorption
Absorption of chlorhexidine from the gastrointestinal tract is very poor. Additionally, an in vivo study in 18 adult patients found no detectable plasma or urine chlorhexidine concentrations following insertion of four periodontal implants under clinical conditions.
Protein Binding
87%
Elimination
Excretion of chlorhexidine gluconate occurred primarily through the feces (~90%). Less than 1% of the chlorhexidine gluconate ingested by these subjects was excreted in the urine.
External Links
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data